導(dǎo)師簡介

姓名:梁超杰性別:男政治面貌:中共黨員學(xué)歷:博士研究生學(xué)位:博士職稱:副教授
博,、碩導(dǎo)師:碩士生導(dǎo)師本崗位工作年數(shù):7年
研究方向:
膽胰外科
榮譽(yù)稱號:
無
學(xué)術(shù)任職:
中國醫(yī)促會腔鏡與內(nèi)鏡分會委員,;中國中西醫(yī)結(jié)合會肝膽外科分會委員;中國抗癌協(xié)會營養(yǎng)分會委員
近五年承擔(dān)科研課題情況:
例如:山西省應(yīng)用基礎(chǔ)研究計劃項(xiàng)目項(xiàng)目名稱:m6A調(diào)控DcR3異常表達(dá)在肝癌發(fā)生發(fā)展中的機(jī)制研究,,項(xiàng)目編號: 201901D211480
代表性論著及近五年的代表性論文(限10項(xiàng)以內(nèi)):
例如:
Liang, Chaowei; Fan, Jiaxin;Liang, Chaojie; Guo, Jiansheng; Identification and Validation of a Pyroptosis-Related Prognostic Model for Gastric Cancer, Frontiers in Genetics, 2022, 12:699503.
Li, Guanqun; Zhang, Dongxin; Liang, Chaowei;Liang, Chaojie; Wu, Jixiang; Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma, Frontiers in oncology, 2022, 12:1021775.
Liang, Chaojie; Shan, Dan; Wei, Zhigang; PDO-Based Drug Screening in Advanced Pancreatic Cancer: Addressing Predictive Value and Broader Clinical Implications, Gastroenterology, 2024, 168: 627-636.
Wei, Zhigang; Shan, Dan;Liang, Chaojie; Does MASH comorbidity in CHB truly suppress immune function? Journal of Hepatology, 2024, S0168-8278:02698-9.
Gong, Xiaowen; Xuan, Yuerong; Pang, Chengshuai; Dong, Chenyang; Cao, Rui; Wei, Zhigang;Liang, Chaojie; DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis, Clinica Chimica Acta, 2025, 567: 120080